PMID: 3321005Nov 1, 1987Paper

Treatment of extensive warts with etretinate: a clinical trial in 20 children

Pediatric Dermatology
C GelmettiS Menni

Abstract

To evaluate the clinical-effectiveness of etretinate in the treatment of papilloma virus infections, 20 children with extensive warts were given this oral retinoid for a period not exceeding three months at a dosage of 1 mg per kg per day. Sixteen patients showed complete regression of the disease without relapse, while in 4, lesions recurred after partial regression had been obtained. A follow-up of two years confirmed these findings. The results of this preliminary study are encouraging. Additional study is needed to determine the ultimate usefulness of etretinate in the treatment of refractory warts.

References

Sep 1, 1979·AJR. American Journal of Roentgenology·M L JohnsonC Rashbaum
Jan 1, 1979·The British Journal of Dermatology·A Rook
Jan 1, 1985·The British Journal of Dermatology·H H RoenigkH Yokoo
Apr 1, 1982·Journal of the American Academy of Dermatology·J McGuireM Osber
Jan 1, 1983·Dermatologica·M MunkvadH Kongsholm
Jan 1, 1984·International Archives of Allergy and Applied Immunology·B I CobleO Stendahl
Apr 1, 1982·Journal of the American Academy of Dermatology·C CamisaG Weissmann
Nov 1, 1984·Clinical and Experimental Dermatology·J H Sillevis Smitt, F de Mari
Feb 1, 1984·Cancer Letters·D Sklan, R Lotan
Jan 1, 1983·Clinical and Experimental Dermatology·J BoyleR M MacKie
Jun 1, 1983·The Journal of Dermatologic Surgery and Oncology·G Mahrle, W Alexander
Oct 1, 1981·Gynecologic Oncology·G L Peck
Apr 1, 1982·Journal of the American Academy of Dermatology·G L PeckJ J DiGiovanna
Apr 1, 1982·Journal of the American Academy of Dermatology·F L Meyskens
May 8, 1980·The New England Journal of Medicine·W M JayC S Hoyt
Apr 1, 1982·Journal of the American Academy of Dermatology·R C Moon, D L McCormick
Jul 1, 1982·Clinical and Experimental Dermatology·J D Oriel
Jan 1, 1982·Archives of Dermatological Research·A Lahti, M Hannuksela

❮ Previous
Next ❯

Citations

Feb 13, 2001·The British Journal of Dermatology·J C SterlingUNKNOWN British Association of Dermatologists
Apr 27, 2011·Pediatric Dermatology·Christina Boull, David Groth
Jan 19, 2012·Virology Journal·Anca Gaston, Robert F Garry
Feb 2, 2012·American Journal of Clinical Dermatology·Federica Dall'oglioGiuseppe Micali
Jan 11, 2007·Clinical Medicine & Research·Michelle M Lipke
Nov 2, 2013·Indian Journal of Dermatology, Venereology and Leprology·Rashmi SarkarVijay K Garg
Oct 3, 2014·The British Journal of Dermatology·J C SterlingS E Handfield-Jones
Oct 16, 2012·Journal of the American Academy of Dermatology·Giovanni Luigi Capella
Jul 1, 1988·Journal of the American Academy of Dermatology·R J Coskey
Apr 29, 2010·The British Journal of Dermatology·A D OrmerodUNKNOWN BAD Clinical Standards Unit
Jan 1, 1995·Journal of the American Academy of Dermatology·L A DrakeB J Lowery
May 7, 2010·The Journal of Dermatological Treatment·Rami H El-Khayat, Joanne S Hague
Feb 6, 2004·Dermatologic Therapy·Patricia T Ting, Marlene T Dytoc
Apr 20, 2001·The Australasian Journal of Dermatology·D L DamianJ F Thompson
Jun 1, 1992·Epidemiology and Infection·J S Nguyen-van-Tam, K G Nicholson
Jun 9, 2016·Current Opinion in Pediatrics·Jane Sterling
Sep 26, 2019·Archivum Immunologiae Et Therapiae Experimentalis·Wangqing ChenXiang Chen
Mar 7, 2020·The Journal of Dermatology·Rena TsukaharaTsuyoshi Mitsuishi
Dec 17, 2020·Cells·Łukasz SzymańskiArthur Zelent
Dec 7, 2020·Dermatology : International Journal for Clinical and Investigative Dermatology·Meital Oren-ShabtaiAssi Levi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved